Your browser doesn't support javascript.
loading
Proton inactivation of melanoma cells enhanced by fotemustine.
Ristic-Fira, Aleksandra; Koricanac, Lela; Zakula, Jelena; Keta, Otilija; Iannolo, Gioacchin; Cuttone, Giacomo; Petrovic, Ivan.
Afiliação
  • Ristic-Fira A; Laboratory of Molecular Biology and Endocrinology, Vinca Institute of Nuclear Sciences, University of Belgrade, PO Box 522, Belgrade 11001, Serbia. aristic@vinca.rs
Radiat Prot Dosimetry ; 143(2-4): 503-7, 2011 Feb.
Article em En | MEDLINE | ID: mdl-21183545
Response of human HTB140 melanoma cells to proton irradiation in combination with fotemustine (FM) was investigated. Effects of these agents were analysed on cell proliferation and induction of apoptosis. Cells pretreated with 100- or 250-µM of FM were irradiated in the middle of the therapeutic 62-MeV proton spread-out Bragg peak, with a dose of 16 Gy. All treatments reduced proliferation and survival of melanoma cells. The most pronounced effects of the combined treatment were obtained for cell survivals. The level of apoptosis increased after all applied treatments. Particularly good pro-apoptotic effect was achieved when proton irradiation was combined with 250 µM of FM. This was followed by the increased expression of p53 gene. The obtained results have shown that combined application of FM and protons significantly reduced growth of this resistant melanoma cell line.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organofosforados / Sobrevivência Celular / Melanoma / Antineoplásicos / Compostos de Nitrosoureia Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organofosforados / Sobrevivência Celular / Melanoma / Antineoplásicos / Compostos de Nitrosoureia Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article